Stocklytics Platform
Asset logo for symbol XPEL
XPEL
XPEL79
$46.38arrow_drop_up1.83%$0.84
High Quality
Asset logo for symbol XPEL
XPEL79

$46.38

arrow_drop_up1.83%

Performance History

Chart placeholder
Key Stats
Open$45.31
Prev. Close$44.85
EPS1.75
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range44.86
47.16
52 Week Range30.75
78.62
Ratios
EPS1.75

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

About XPEL (XPEL)

XPEL Inc (XPEL) is a leading provider of protective films and coatings for automotive and architectural surfaces. The company is known for its innovative products that offer superior protection against scratches, UV rays, and other environmental damage. With a track record of strong financial performance and a growing customer base, XPEL has positioned itself as a leader in the industry.
The stock price of XPEL has experienced significant growth over the years. In January 2020, the stock was trading at around $15 per share. However, by February 2021, the stock price had skyrocketed to over $50 per share. This impressive growth can be attributed to several factors, including the company's solid financial performance and its successful expansion into new markets.
Websitecall_made
Sector
Consumer Cyclical
Industry
Auto Parts
CEO
Mr. Ryan L. Pape
Headquarters
San Antonio
Employees
818
Exchange
NASDAQ
add XPEL to watchlist

Keep an eye on XPEL

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is XPEL 's (XPEL) price per share?

The current price per share for XPEL (XPEL) is $46.38. The stock has seen a price change of $0.84 recently, indicating a 1.84% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for XPEL (XPEL)?

For XPEL (XPEL), the 52-week high is $78.62, which is 69.5% from the current price. The 52-week low is $30.75, the current price is 50.84% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is XPEL (XPEL) a growth stock?

XPEL (XPEL) has shown an average price growth of -3.36% over the past three years. It has received a score of 28 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying XPEL as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is XPEL (XPEL) stock price performance year to date (YTD)?

As of the latest data, XPEL (XPEL) has a year-to-date price change of -13.86%. Over the past month, the stock has experienced a price change of 16.63%. Over the last three months, the change has been 0.66%. Over the past six months, the figure is 31.85%. Looking at a longer horizon, the five-year price change stands at 195.44%.
help

Is XPEL (XPEL) a profitable company?

XPEL (XPEL) has a net income of $52.8M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 40.98% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 16.29% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $396.29M, with a revenue growth rate of 22.32%, providing insight into the company's sales performance and growth. The gross profit is $162.41M. Operating income is noted at $66.97M. Furthermore, the EBITDA is $72.36M.
help

What is the market capitalization of XPEL (XPEL)?

XPEL (XPEL) has a market capitalization of $1.29B. The average daily trading volume is 46.45, indicating the stock's liquidity and investor engagement.

News

התראת מועד לתביעה נגד INDV: רוזן, יועץ למשקיעים מוכר, מעודד את משקיעי XPEL, Inc. שצברו הפסדים של יותר מ- 100 אלף דולר, להבטיח ייעוץ לפני תאריך יעד חשוב של 7 באוקטובר בתביעה ייצוגית בניירות ערך – XPEL
XPEL
SECURITIES CLASS ACTION
INVESTMENT LOSSES
Sep 29, 2024

התראת מועד לתביעה נגד INDV: רוזן, יועץ למשקיעים מוכר, מעודד את משקיעי XPEL, Inc. שצברו הפסדים של יותר מ- 100 אלף דולר, להבטיח ייעוץ לפני תאריך יעד חשוב של 7 באוקטובר בתביעה ייצוגית בניירות ערך – XPEL

XPEL DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages XPEL, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 7 Deadline in Securities Class Action – XPEL
XPEL
SECURITIES CLASS ACTION
FALSE AND MISLEADING STATEMENTS
Sep 29, 2024

XPEL DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages XPEL, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 7 Deadline in Securities Class Action – XPEL

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages XPEL, Inc. Investors to Secure Counsel Before Important October 7 Deadline in Securities Class Action – XPEL
XPEL
SECURITIES CLASS ACTION
CLASS PERIOD
Sep 26, 2024

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages XPEL, Inc. Investors to Secure Counsel Before Important October 7 Deadline in Securities Class Action – XPEL

XPEL Investors Have Opportunity to Lead XPEL, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm
XPEL
SECURITIES FRAUD
LAWSUIT
MARKET SHARE
REVENUE GROWTH
Sep 25, 2024

XPEL Investors Have Opportunity to Lead XPEL, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages XPEL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XPEL
XPEL
SECURITIES CLASS ACTION
Sep 23, 2024

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages XPEL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – XPEL

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
MODERNA
LULULEMON
XPEL
NANO NUCLEAR
CLASS ACTION LAWSUIT
Sep 22, 2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

Take Your Investments to a Whole New Level